FG
Frederick G Vogt
DELAYED 1 MONTH
Director, Interim CEO & General Counsel
IOVANCE BIOTHERAPEUTICS, INC.
Filings
5
Companies
1
Latest
Jun 5, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
IOVANCE BIOTHERAPEUTICS, INC.
Frederick G Vogt
Director, Interim CEO & General Counsel
Option Exercise
—
15,625 sh
Jun 9 9:03 PM
Jun 5, 2026
—
IOVANCE BIOTHERAPEUTICS, INC.
Frederick G Vogt
Director, Interim CEO & General Counsel
Option Exercise
—
41,668 sh
Jun 3 9:02 PM
Jun 1, 2026
—
IOVANCE BIOTHERAPEUTICS, INC.
Frederick G Vogt
Director, Interim CEO & General Counsel
Option Exercise
—
62,493 sh
Mar 6 10:02 PM
Mar 5, 2026
—
IOVANCE BIOTHERAPEUTICS, INC.
Frederick G Vogt
Director, Interim CEO & General Counsel
Option Exercise
—
52,087 sh
Mar 4 10:01 PM
Mar 2, 2026